Johnny N Mahlangu

54PUBLICATIONS
117CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Aerodynamics (excl. hypersonic aerodynamics)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Jul 08, 2026
Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapies.

|Apr 29, 2026
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

|Feb 27, 2026
Is marstacimab the next step in personalized and effective haemophilia management?

Johnny Mahlangu

|Feb 12, 2026
A revised classification of FVIII concentrates: rationale and novel metrics.

Cédric Rjr Hermans, Pratima Chowdary, Barbara A Konkle

|Jan 07, 2026
Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study.

Johnny Mahlangu, Ana Boban, Maria Bruzelius

|Dec 06, 2025
Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial.

Davide Matino, Suchitra S Acharya, Carrie Turich Taylor

Pageof 9

Frequent Collaborators

9 joint publications

Guy Young

8 joint publications

Manuel Carcao

7 joint publications

Steven W Pipe

7 joint publications

Victor Jiménez-Yuste